当前位置: X-MOL首页全球导师 国内导师 › 王继闯

个人简介

王继闯,男,1985年10月出生,中共党员,博士。2015年10月来校工作,于2015年6月毕业于福州大学生物化工专业。主要从事肝癌靶向治疗及其耐药、抗癌药物药理学、肿瘤转移等相关分子研究。主持省部级项目2项、厅级项目2项、校级项目1项,受委托主持卫教联合攻关项目1项,指导博士生获研究生启航基金项目1项。累计在国内外SCI学术刊物上发表论文二十余篇,其中第一作者/共同第一作者发表SCI论文7篇。

研究领域

肝癌靶向治疗及其耐药、

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

[1]JichuangWang#,NanZhang#,QiHan,WenxianLu,LongWang,DayunYang,MinZheng,ZhenzhenZhang,HekunLiu,TaeHoLee,XiaoZhenZhou,KunPingLu*,Pin1inhibitionreversestheacquiredresistanceofhumanhepatocellularcarcinomacellstoRegorafenibviatheGli1/Snail/E-cadherinpathway,CancerLetters,2019,444:82–93 [2]JichuangWang#,Xin-HuaLiao#,MinZheng,DayunYang,XiaoZhenZhou,HekunLiu*,KunPingLu*,TherolesoftheuniqueprolylisomerasePin1incancer-relatedviralandbacterialinfections,CurrentMolecularMedicine,2016,16(9):793-802 [3]JichuangWang#,JianzhongChen#,YeweiZhu,NingZheng,JianLiu,YingyingXiao,YushengLu,HaiyanDong,JingjingXie,SuhongYu,JingweiShao,LeeJia*,InVitroandinVivoEfficacyandSafetyEvaluationofMetapristoneandMifepristoneasCancerMetastaticChemopreventiveAgents,BiomedicineandPharmacotherapy,2016,78:291-300 [4]JichuangWang#,ZhouJiang#,LipingXiang,YuanfangLi,MinruiOu,XiangYang,JingweiShao*,YushengLu,LifengLin,JianzhongChen,YunDai,LeeJia*,SynergismofUrsolicAcidDerivativeUS597with2-deoxy-D-glucosetoPreferentiallyInduceTumorCellDeathbyDual-targetingofApoptosisandGlycolysis,ScientificReports,2014,4:5006 [5]JichuangWang#,JianzhongChen#,LiyuanWan,JingweiShao*,YushengLu,YeweiZhu,MinruiOu,SuhongYu,HaijunChen,LeeJia*,Synthesis,SpectralCharacterization,andinVitroCellularActivitiesofMetapristone,aPotentialCancerMetastaticChemopreventiveAgentDerivedfromMifepristone(RU486),TheAAPSJournal,2014,16(2):289-298

推荐链接
down
wechat
bug